Patents by Inventor Joachim Lupberger

Joachim Lupberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DIAGNOSIS AND/OR PROGNOSIS OF LIVER DISEASE PROGRESSION AND RISK OF HEPATOCELLULAR CARCINOMA AND DISCOVERY OF THERAPEUTIC COMPOUNDS AND TARGETS TO TREAT LIVER DISEASE AND CANCER
    Publication number: 20230313299
    Abstract: The present invention relates to diagnosis and/or prognosis of liver disease progression and risk of hepatocellular carcinoma and the discovery of therapeutic compounds and targets to treat liver disease and cancer.
    Type: Application
    Filed: March 2, 2021
    Publication date: October 5, 2023
    Inventors: Thomas BAUMERT, Joachim LUPBERGER, Frank Sven JÜHLING, Yujin HOSHIDA
  • Host cell kinases as targets for antiviral therapies against HCV infection
    Patent number: 8759010
    Abstract: The present invention provides several networks of cellular protein kinases as potential targets for medical intervention against hepatitis C virus (HCV) infection and HCV-related diseases and disorders in mammals, including humans. The invention relates to therapeutic protocols and pharmaceutical compositions designed to inhibit the activity of one or more of these protein kinases for the prevention and/or treatment of infections and diseases caused by HCV. The invention also relates to methods for the identification of kinase inhibitors that may be used to treat and/or prevent HCV infections and HCV-related diseases.
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: June 24, 2014
    Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Thomas Baumert, Joachim Lupberger
  • Host Cell Kinases as Targets for Antiviral Therapies Against HCV Infection
    Publication number: 20110229484
    Abstract: The present invention provides several networks of cellular protein kinases as potential targets for medical intervention against hepatitis C virus (HCV) infection and HCV-related diseases and disorders in mammals, including humans. The invention relates to therapeutic protocols and pharmaceutical compositions designed to inhibit the activity of one or more of these protein kinases for the prevention and/or treatment of infections and diseases caused by HCV. The invention also relates to methods for the identification of kinase inhibitors that may be used to treat and/or prevent HCV infections and HCV-related diseases.
    Type: Application
    Filed: September 18, 2009
    Publication date: September 22, 2011
    Applicant: INSERM (Institut National de la Sant et de la Recherche Medicale)
    Inventors: Thomas Baumert, Joachim Lupberger